 |
 |
|
News |
|
|
|
|
|
|
|
|
|
April
30, 2008
QIAGEN and BioHelix enter into
licensing agreement. |
| |
April
3, 2008
BioHelix Corporation was awarded
three NIH grants to develop diagnostic assays based on its proprietary
HDA technologies.
|
| BioHelix announced today that it was awarded
three Small Business Innovative Research (SBIR) grants from the National
Institutes of Health. Two phase I SBIR grants for the development
of diagnostic assays based on BioHelix "instrument-free"
IsoAmp platform. One supports the development of IsoAmp Group B Strep
assay for detecting colonization by Streptococcus agalactiae in pregnant
women and one supports the development of low-cost IsoAmp HIV assay.
In addition, the company also receives a 3-year phase 2 award for
developing Herpes virus typing assay for detecting genital herpes
based on an isothermal realtime detection platform. The SBIR awards
will enable BioHelix to continue developing innovative isothermal
amplification technologies for use in clinical diagnostics. |
| |
November
1 , 2007
BioHelix Corporation Launches IsoAmp®
RUO Rapid Staph Detection Kit.
|
| |
March
12, 2007
BioHelix Corporation receives
contract from the Department of Homeland Security to develop Next-Generation
Molecular Diagnostics. |
| |
April
24, 2006
Whole Genome Amplification licensing
agreement with Harvard University
|
| |
June
16, 2005
BioHelix Corporation receives
award from the Department of Homeland Security to develop portable
diagnostic tools.
|
| |
June
16, 2005
The research article reporting
the thermophilic-HDA system is published in JBC.
|
| |
May
12, 2005
BioHelix Corporation launched
IsoAmp® tHDA Kit.
|
| |
| |
March
16, 2005
BioHelix Corporation was awarded
two NIH grants to develop new HDA technologies.
|
| |
| |
|
|
|
|
